Parameter
| Biomarker | PiR - 162725. | Full name | piRNA-162725 | Molecular Type | piRNA |
|---|---|---|---|---|---|
| Molecular Formula | Molecular Weight | Core Functional Dimensions | Early diagnosis, differential diagnosis | ||
| Disease | Pancreatic Cancer | Disease Subtypes | / | ||
| Organ | Pancreas | Test Sample / Technology Platform | Blood (liquid biopsy), tissue (next generation sequencing) | ||
| Pathobiological Mechanisms | Driven by PIWIL3 expression, enrichment in the MAPK, TGF - beta and Hippo to promote tumor signaling pathways, involved in regulating cell proliferation and tumor | ||||
| Clinical Availability Status | Clinical research phase: detected in liquid biopsy, PDAC can be distinguished from healthy people and precancerous lesions | ||||
| Notes and Dynamics | And CA19-9 joint diagnosis sensitivity can be increased from about 75% to 89.7%, does not affect the clinical treatment strategy choice, just as a diagnostic aid markers | ||||